Morningstar Investor users sign in here.

Company Profile

  • Business description

    Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.

  • Contact

    Sanders Road
    Unit 202, Bellhouse Building
    Oxford Science Park
    Oxford OX4 4GD
    GBR

    T: +44 1865582066

    https://www.scancell.co.uk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 April 2025

    Employees

    49

Stocks News & Analysis

stocks

The secrets of Australia’s Berkshire Hathaway

Washington H. Soul Pattinson is an ASX top 50 stock with one of the best investment track records this country has seen. Yet, most Australians haven’t heard of it, and the company seems to prefer it that way.
stocks

Have some of the ASX 200's worst performers fallen too far?

These four stocks have had an awful twelve months. Morningstar's analysts weigh in on whether they offer good value yet. 
stocks

Private equity bid dramatically undervalues ASX listed share

We believe the bid is an attempt to capitalise on share price weakness. 

Markets

Index
Last price
Change
% Change
All Ordinaries 8,002.50 39.40 0.49%
CAC 40 7,764.31 100.39 -1.28%
DAX 40 18,404.35 226.51 -1.22%
Dow JONES (US) 38,712.21 35.21 -0.09%
FTSE 100 8,173.77 41.71 -0.51%
HKSE 18,112.63 174.79 0.97%
NASDAQ 17,608.44 264.89 1.53%
Nikkei 225 38,720.47 156.24 -0.40%
NZX 50 Index 11,872.64 130.76 1.11%
S&P 500 5,421.03 45.71 0.85%
S&P/ASX 200 7,749.70 34.20 0.44%
SSE Composite Index 3,028.92 8.55 -0.28%

Market Movers

Name
Last price
Change
% Change
Sigma Healthcare Ltd SIG 1.16 0.05 -3.73%
Peninsula Energy Ltd PEN 0.10 0.00 4.17%
South32 Ltd S32 3.64 0.00 0.00%
Pilbara Minerals Ltd PLS 3.32 0.09 -2.64%
Telstra Group Ltd TLS 3.53 0.01 0.28%
Core Lithium Ltd CXO 0.09 0.00 -1.05%
Red 5 Ltd RED 0.44 0.01 1.15%
Mirvac Group MGR 1.93 0.03 1.58%
TerraCom Ltd TER 0.22 0.01 -2.27%
Imugene Ltd IMU 0.06 0.00 1.75%